IDL Biotech AB
IDL Biotech

CLOSE MENU

What is IDL Biotech?

Saving lives with diagnostics

IDL Biotech AB - provides knowledge to decision

IDL Biotech is a diagnostic company that develops, produces, and markets In Vitro Diagnostic (IVD) tests worldwide for the health care sector. We are active in the fields of oncology and bacteriology through manufacturing of various tumor markers and a rapid Salmonella typhoid test. IDL Biotech AB (publ) is a public company listed on the Swedish equities market place, Spotlight Stock Market.

Jerker Swanstein new Chairman of the Board of Directors

The annual general meeting, held 28th of May 2019, re-elected Jerker Swanstein, Per-Anders Abrahamsson and Carsten Olsson, and elected Malin Ruijsenaars and Eva Sjökvist Saers as new members of the Board of Directors. During the statutory meeting held 28th of May 2019 Jerker Swanstein was selected as new Chairman of the Board of Directors.

Information from the Annual General Meeting

The Annual General meeting was held on the 28th of May 2019.

German study recommends UBC® Rapid to be added in the diagnostics and follow-up of high risk bladder cancer

International Journal of Molecular Sciences has published a study on UBC® Rapid. In total 530 urine samples was included in the multicenterstudy.

IDL Biotech

Skip this intro